ResMed Inc. (RMD)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 183.42 |
| Open | 203.02 |
| Bid | 217.76 x 800 |
| Ask | 217.95 x 900 |
| Day's range | 201.86 - 218.38 |
| 52-week range | 132.24 - 240.09 |
| Volume | |
| Avg. volume | 1,070,944 |
| Market cap | 32.074B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 36.10 |
| EPS (TTM) | 6.04 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 1.92 (0.88%) |
| Ex-dividend date | 08 May 2024 |
| 1y target est | 202.68 |
GuruFocus.comDecoding ResMed Inc (RMD): A Strategic SWOT Insight
Insightful Analysis of ResMed Inc's Financial Health and Strategic Position
Investor's Business DailyHow 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed
ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.
ZacksInteger Holdings (ITGR) Q1 Earnings Top Estimates, Margins Up
Integer Holdings' (ITGR) first-quarter results reflect robust Medical Sales, along with strength in all the product lines.
© 2024 Yahoo. All rights reserved.